RPID

Rapid Micro Biosystems Inc
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$112.59M
P/E Ratio
EPS
$-1.00
Beta
1.60
52W High
$4.94
52W Low
$2.01
50-Day MA
$3.00
200-Day MA
$3.31
Dividend Yield
Profit Margin
-140.30%
Forward P/E
PEG Ratio
0.00

About Rapid Micro Biosystems Inc

Rapid Micro Biosystems Inc (RPID) is a pioneering biotechnology firm dedicated to transforming microbiological quality control within the pharmaceutical and biotechnology sectors. The company leverages cutting-edge automated growth-based microbial detection technologies to enhance the accuracy and efficiency of microbial testing, thereby ensuring stringent product quality and compliance with regulatory standards. Positioned at the forefront of an expanding market that demands swift and dependable quality assurance solutions, Rapid Micro is poised to lead the advancement of innovative testing methodologies critical to maintaining safety and excellence in regulated environments.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$33.59M
Gross Profit (TTM)$1.05M
EBITDA$-44.64M
Operating Margin-108.20%
Return on Equity-86.80%
Return on Assets-34.20%
Revenue/Share (TTM)$0.75
Book Value$0.75
Price-to-Book3.39
Price-to-Sales (TTM)3.35
EV/Revenue3.216
EV/EBITDA0.82
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)37.30%
Shares Outstanding$41.27M
Float$22.38M
% Insiders9.94%
% Institutions57.28%

Historical Volatility

HV 10-Day
75.11%
HV 20-Day
73.55%
HV 30-Day
74.14%
HV 60-Day
96.78%
HV Rank
19.4%

Volatility is currently expanding

Analyst Ratings

Consensus ($8.00 target)
4
Buy
Data last updated: 4/29/2026